Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Prospective real-world evaluation of SKY92 for risk stratification in multiple myeloma: Comparison with updated ims/IMWG criteria in the prommis study

Noa Biran, Binod Dhakal, Ruben Niesvizky, Suzanne Lentzsch, Raja Prince-Eladnani, Ajay Nooka, David Vesole, Barry Paul, Parameswaran Hari, Silvia D'Ambrosi, Rowan Kuiper, Martin Van Vliet, David Siegel, Saad Usmani, Frits van Rhee

Blood (2025) 146 (Supplement 1): 2220.

https://doi.org/10.1182/blood-2025-2220

Published: 2025

Journal Articles

The presence of SH2B3 mutations identifies a distinct subtype of myelodysplastic neoplasms

Blood (2025) 146 (Supplement 1): 2070.

https://doi.org/10.1182/blood-2025-2070

Published: 2025

Journal Articles

Refining the prognostic hierarchy of TP53 multihit alterations and isolated deletion of chromosome 5q in myelodysplastic syndromes

Blood (2025) 146 (Supplement 1): 2068.

https://doi.org/10.1182/blood-2025-2068

Published: 2025

Journal Articles

Risk factors for cytokine release syndrome and neurotoxicity in patients receiving epcoritamab or glofitamab for large B cell lymphoma: A multi-center, retrospective, real world analysis.

Blood (2025) 146 (Supplement 1): 401.

https://doi.org/10.1182/blood-2025-401

Published: 2025

Journal Articles

Characterization and outcomes of patients with indolent Mantle Cell Lymphoma (iMCL) in Spain. the GELTAMO-MCL-2022 Study

Ana Marin Niebla, Eva Gine, Mariana Bastos-Oreiro, Amanda Perez, Alba Cabirta, Fatima De la Cruz Vicente, Marta Canelo Vilaseca, Ana Jiménez Ubieto, Sonia González De Villambrosia, Ana Muntanola Prat, Eva Gonzalez Barca, Hugo Daniel Luzardo Henríquez, Eduardo Rios Herranz, Pilar Gomez Prieto, Raul Cordoba, Ana Saus Carreres, Alejandro Martin Garcia-Sancho, Ana Maria Garcia-Noblejas Moya, Carlos Grande, Pablo Prieto Martínez, Concepción Nicolás, Antonio Gutierrez, Jose Angel Hernandez Rivas, Blanca Sánchez-González, Maria Teresa Villalobos, Tomas García-Cerecedo, Rosalia Alonso Trillo, Eva Donato, Paola Villafuerte Gutiérrez, Daniel García Belmonte, Silvia Rocio Verdesoto Cozzarelli, Sandra Suarez Ordoñez, Emilia Pardal De La Mano, Amparo Avaría, Lucia Villalon Blanco, Alicia Roldán-Pérez, Juan-Manuel Sancho, Beatriz De La Cruz, Raja Prince-Eladnani, Pau Abrisqueta

Blood (2025) 146 (Supplement 1): 3592.

https://doi.org/10.1182/blood-2025-3592

Published: 2025

Journal Articles

Predicting survival outcomes in CAR-t treated B-cell lymphoma by combining PET/CT imagingand clinical features

Blood (2025) 146 (Supplement 1): 5487.

https://doi.org/10.1182/blood-2025-5487

Published: 2025

Journal Articles

Induction chemotherapy with a single anthracycline-containing cycle in younger adults with newly diagnosed AML – the french backbone intergroup (BIG)-1 study on behalf of the filo, ALFA, and SFGM-TC study groups

Blood (2025) 146 (Supplement 1): 43.

https://doi.org/10.1182/blood-2025-43

Published: 2025

Journal Articles

Synergistic correction of polycythemia vera phenotype via dual targeting of JAK2 and Gas6 in Jak2 exon 12 mutant mice

Tanja Knopp, Introini Elisa, Rim Diab, Caku Sara, Mariantonietta Tripodo, Etzensperger Ruth, Raja Prince-Eladnani, Radek Skoda, Sara C Meyer, Alicia Rovó, Anne Angelillo-Scherrer

Blood (2025) 146 (Supplement 1): 5056.

https://doi.org/10.1182/blood-2025-5056

Published: 2025

Journal Articles

In Vivo correction of the sickle cell disease mutation in hematopoietic stem cells using RNA gene writers

Blood (2025) 146 (Supplement 1): 2536.

https://doi.org/10.1182/blood-2025-2536

Published: 2025

Journal Articles

Post-transplant monitoring of multiparameter flow-cytometry (MFC)-based measurable residual disease (MRD) assessment combined with T-cell chimerism following allogeneic stem cell transplantation (HCT) in Acute Myeloid Leukemia (AML) and myelodysplastic syndrome (MDS)

Reem Alasbali, Majed Altareb, Carol Chen, Tommy Alfaro Moya, Eshrak Al-Shaibani, Swe Linn, Ivan Pasic, Igor Novitzky-Basso, Arjun Law, Fotios Michelis, Auro Viswabandya, Rajat Kumar, Jonas Mattsson, Raja Prince-Eladnani, Anne Tierens, Dennis Kim

Blood (2025) 146 (Supplement 1): 4295.

https://doi.org/10.1182/blood-2025-4295

Published: 2025

Journal Articles

Validation of the FL/IL6 score, a new dynamic cytokine-based risk-model in adults with acute myeloid leukemia, a prospective multicentre filo study.

Blood (2025) 146 (Supplement 1): 5247.

https://doi.org/10.1182/blood-2025-5247

Published: 2025

Journal Articles

Enhancing hemostasis in glanzmann thrombasthenia via protein S inhibition

Rim Diab, Tanja Knopp, Mathieu Fiore, Sonia Avoue-celerier, Léonard Julien Simon Schacher, Raja Prince-Eladnani, Anne Angelillo-Scherrer

Blood (2025) 146 (Supplement 1): 3025.

https://doi.org/10.1182/blood-2025-3025

Published: 2025

Journal Articles

ALIDHE: An ongoing open-label phase 3b study investigating ivosidenib with azacitidine in clinical practice in adult patients with newly diagnosed mutant isocitrate dehydrogenase 1 (mIDH1) Acute Myeloid Leukemia (AML) ineligible for intensive induction chemotherapy (IC)

Blood (2025) 146 (Supplement 1): 3443.

https://doi.org/10.1182/blood-2025-3443

Published: 2025

Journal Articles

Is dual targeting of FXII and Gas6 a good strategy to prevent thrombosis with no risks of bleeding?

Mariantonietta Tripodo, Tanja Knopp, Thomas Renné, Ilaria De Simone, Bas De Laat, Dana Huskens, Raja Prince-Eladnani, Anne Angelillo-Scherrer

Blood (2025) 146 (Supplement 1): 14.

https://doi.org/10.1182/blood-2025-14

Published: 2025

Journal Articles

Frequency and impact of FLT3-ITD microclones in younger AML patients

Blood (2025) 146 (Supplement 1): 456.

https://doi.org/10.1182/blood-2025-456

Published: 2025

Journal Articles

Real world experience with brecadd protocol as frontline therapy for patients with advanced stage classical Hodgkin lymphoma: A multicenter retrospective study

Blood (2025) 146 (Supplement 1): 3618.

https://doi.org/10.1182/blood-2025-3618

Published: 2025

Journal Articles

Enhancing joint and bone health outcome in Hemophilia A by protein S inhibition

Raja Prince-Eladnani, Rim Diab, Daniela Frauchiger, Patrick Schlegel, Alexia Pollaci, Mathieu Simon, Kurt Lippuner, Philippe Zysset, Anne Angelillo-Scherrer

Blood (2025) 146 (Supplement 1): 1279.

https://doi.org/10.1182/blood-2025-1279

Published: 2025

Journal Articles

Integrated multi-omic profiling reveals two biologically distinct subgroups of splenic marginal zone lymphoma with prognostic relevance

Blood (2025) 146 (Supplement 1): 353.

https://doi.org/10.1182/blood-2025-353

Published: 2025

Journal Articles

Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus

Sara Calzavarini, Raja Prince-Eladnani, François Saller, Luca Bologna, Laurent Burnier, Anne C. Brisset, Claudia Quarroz, Maria Desiré Reina Caro, Vladimir Ermolayev, Yasuhiro Matsumura, José A. Fernández, Tilman M. Hackeng, John H. Griffin, Anne Angelillo-Scherrer

Blood (2020) 135 (22): 1969–1982.

https://doi.org/10.1182/blood.2019003630

Published: 2020

Includes: Multimedia, Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Prospective real-world evaluation of SKY92 for risk stratification in multiple myeloma: Comparison with updated ims/IMWG criteria in the prommis study

The presence of SH2B3 mutations identifies a distinct subtype of myelodysplastic neoplasms

Refining the prognostic hierarchy of TP53 multihit alterations and isolated deletion of chromosome 5q in myelodysplastic syndromes

Risk factors for cytokine release syndrome and neurotoxicity in patients receiving epcoritamab or glofitamab for large B cell lymphoma: A multi-center, retrospective, real world analysis.

Characterization and outcomes of patients with indolent Mantle Cell Lymphoma (iMCL) in Spain. the GELTAMO-MCL-2022 Study

Predicting survival outcomes in CAR-t treated B-cell lymphoma by combining PET/CT imagingand clinical features

Induction chemotherapy with a single anthracycline-containing cycle in younger adults with newly diagnosed AML – the french backbone intergroup (BIG)-1 study on behalf of the filo, ALFA, and SFGM-TC study groups

Synergistic correction of polycythemia vera phenotype via dual targeting of JAK2 and Gas6 in Jak2 exon 12 mutant mice

In Vivo correction of the sickle cell disease mutation in hematopoietic stem cells using RNA gene writers

Post-transplant monitoring of multiparameter flow-cytometry (MFC)-based measurable residual disease (MRD) assessment combined with T-cell chimerism following allogeneic stem cell transplantation (HCT) in Acute Myeloid Leukemia (AML) and myelodysplastic syndrome (MDS)

Validation of the FL/IL6 score, a new dynamic cytokine-based risk-model in adults with acute myeloid leukemia, a prospective multicentre filo study.

Enhancing hemostasis in glanzmann thrombasthenia via protein S inhibition

ALIDHE: An ongoing open-label phase 3b study investigating ivosidenib with azacitidine in clinical practice in adult patients with newly diagnosed mutant isocitrate dehydrogenase 1 (mIDH1) Acute Myeloid Leukemia (AML) ineligible for intensive induction chemotherapy (IC)

Is dual targeting of FXII and Gas6 a good strategy to prevent thrombosis with no risks of bleeding?

Frequency and impact of FLT3-ITD microclones in younger AML patients

Real world experience with brecadd protocol as frontline therapy for patients with advanced stage classical Hodgkin lymphoma: A multicenter retrospective study

Enhancing joint and bone health outcome in Hemophilia A by protein S inhibition

Integrated multi-omic profiling reveals two biologically distinct subgroups of splenic marginal zone lymphoma with prognostic relevance

Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only